APA (7th ed.) Citation

Dahan, A. E., Azran, C., & Dahan, A. (2026). Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective. Pharmaceutics, 18(4), 466. https://doi.org/10.3390/pharmaceutics18040466

Chicago Style (17th ed.) Citation

Dahan, Almog Eliyahu, Carmil Azran, and Arik Dahan. "Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective." Pharmaceutics 18, no. 4 (2026): 466. https://doi.org/10.3390/pharmaceutics18040466.

MLA (9th ed.) Citation

Dahan, Almog Eliyahu, et al. "Is Oral Semaglutide a Good Fit for Patients After Metabolic Bariatric Surgery? A Biopharmaceutical Mechanistic Perspective." Pharmaceutics, vol. 18, no. 4, 2026, p. 466, https://doi.org/10.3390/pharmaceutics18040466.

Warning: These citations may not always be 100% accurate.